|
TRIM62 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.031800E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.457000E-03 |
| Normal-vs-Stage2 |
4.566000E-01 |
| Normal-vs-Stage3 |
3.009200E-01 |
| Normal-vs-Stage4 |
4.824200E-02 |
| Stage1-vs-Stage2 |
1.607400E-01 |
| Stage1-vs-Stage3 |
3.498600E-01 |
| Stage1-vs-Stage4 |
1.687360E-01 |
| Stage2-vs-Stage3 |
7.977800E-01 |
| Stage2-vs-Stage4 |
1.022440E-01 |
| Stage3-vs-Stage4 |
1.529650E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.023760E-02 |
| Normal-vs-AfricanAmerican |
4.137800E-02 |
| Normal-vs-Asian |
5.349400E-01 |
| Caucasian-vs-AfricanAmerican |
9.090800E-01 |
| Caucasian-vs-Asian |
6.753000E-01 |
| AfricanAmerican-vs-Asian |
6.964600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.844700E-03 |
| Normal-vs-Female |
9.390000E-01 |
| Male-vs-Female |
3.729800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.006200E-02 |
| Normal-vs-Extreme_Weight |
1.402340E-03 |
| Normal-vs-Obese |
1.645640E-02 |
| Normal-vs-Extreme_Obese |
8.141900E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.884400E-01 |
| Normal_Weight-vs-Obese |
9.922200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.763000E-01 |
| Extreme_Weight-vs-Obese |
4.452400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.104000E-01 |
| Obese-vs-Extreme_Obese |
9.733000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.425200E-01 |
| Normal-vs-Age(41-60Yrs) |
8.144400E-02 |
| Normal-vs-Age(61-80Yrs) |
1.283980E-02 |
| Normal-vs-Age(81-100Yrs) |
5.249600E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.020600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.595200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.937600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.251200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.222200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.818400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.603400E-03 |
| Normal-VS-Type2 PRCC |
1.078100E-03 |
| Normal-VS-KIRP CIMP |
3.066400E-01 |
| Normal-VS-Unclassified PRCC |
6.674000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.908600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.051900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.602450E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.895100E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.527850E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.426000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.813700E-04 |
| Normal-vs-N1 |
4.023600E-01 |
| Normal-vs-N2 |
7.946200E-01 |
| N0-vs-N1 |
3.473800E-01 |
| N0-vs-N2 |
7.014000E-01 |
| N1-vs-N2 |
9.574000E-01 |
|
|
